Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

5432 Results

Document

Patients-Biologic-drugs-how-they-are-approved-in-Canada.pdf

Jan 2024

Document

Patients-Biologic-drugs-how-they-are-approved-in-Canada-FR.pdf

Jan 2024

Document

Patients-Switching-from-a-reference-biologic-to-a-biosimilar-biologic.pdf

Jan 2024

Document

Patients-Switching-from-a-reference-biologic-to-a-biosimilar-biologic-FR.pdf

Jan 2024

Guidelines and Advice

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Status: Current
Version: 1.0

Jan 2024

Document

OH-CCO-SarcomaServicesProvincialPlan.pdf

Feb 2024

Document

OH-CCO-SarcomaServicesProvincialPlan-FR.pdf

Feb 2024

Document

obsp-2-6-24.xml

Feb 2024

Document

OBSP-2-6-24.html

Feb 2024

Drug

selinexor

Other Name(s): Xpovio®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Mar 2024

Document

dapColorectal15Feb2024.xml

Feb 2024

Document

dapColorectal15Feb2024.html

Feb 2024

Pages